Clinical Trial Update: A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Avastin (bevacizumab) plus Xeloda (capecitabine) as maintenance therapy in metastatic colorectal cancer has completed. Results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-08-08